CRON (STOCKS)
Cronos Group Inc. Common Share
$2.571500
-0.008500 (-0.33%)
Prev close: $2.580000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Michael Ryan Gorenstein
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $981.06M
- Employees
- 459
- P/E (TTM)
- -104.47
- P/B (TTM)
- 0.90
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.00 | $0.01 | -0.0142 | -139.22% |
|
Sep 2025 (Q3)
|
$0.08 | $0.00 | +0.0800 | +0.00% |
|
Jun 2025 (Q2)
|
$-0.10 | $-0.02 | -0.0796 | -390.20% |
|
Mar 2025 (Q1)
|
$0.02 | $0.00 | +0.0200 | +0.00% |
Financial Statements
| Revenues | $146.59M |
| Benefits Costs and Expenses | $163.71M |
| Cost Of Revenue | $83.83M |
| Costs And Expenses | $163.71M |
| Gross Profit | $62.76M |
| Nonoperating Income/Loss | $275.00K |
| Operating Expenses | $80.15M |
| Depreciation and Amortization | $2.12M |
| Research and Development | $4.45M |
| Other Operating Expenses | $73.59M |
| Operating Income/Loss | -$17.40M |
| Income/Loss From Continuing Operations After Tax | -$2.93M |
| Income/Loss From Continuing Operations Before Tax | -$17.12M |
| Income/Loss From Discontinued Operations Net Of Tax | $0.00 |
| Income/Loss From Equity Method Investments | $0.00 |
| Income Tax Expense/Benefit | -$14.19M |
| Income Tax Expense/Benefit, Current | -$15.32M |
| Income Tax Expense/Benefit, Deferred | $1.13M |
| Net Income/Loss | -$2.93M |
| Net Income/Loss Attributable To Noncontrolling Interest | $6.52M |
| Net Income/Loss Attributable To Parent | -$9.45M |
| Net Income/Loss Available To Common Stockholders, Basic | -$9.45M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $4.86M |
| Basic Earnings Per Share | -$0.02 |
| Diluted Earnings Per Share | -$0.02 |
| Basic Average Shares | 383,468,522 |
| Diluted Average Shares | 383,468,522 |
| Assets | $1.20B |
| Current Assets | $944.09M |
| Cash | $831.79M |
| Inventory | $46.75M |
| Other Current Assets | $65.54M |
| Noncurrent Assets | $253.05M |
| Fixed Assets | $145.87M |
| Intangible Assets | $8.89M |
| Other Non-current Assets | $98.30M |
| Liabilities | $54.18M |
| Current Liabilities | $48.19M |
| Accounts Payable | $11.64M |
| Wages | $9.46M |
| Other Current Liabilities | $27.08M |
| Noncurrent Liabilities | $5.99M |
| Equity | $1.14B |
| Equity Attributable To Noncontrolling Interest | $49.06M |
| Equity Attributable To Parent | $1.09B |
| Liabilities And Equity | $1.20B |
| Net Cash Flow From Operating Activities | $25.87M |
| Net Cash Flow From Operating Activities, Continuing | $25.87M |
| Net Cash Flow From Investing Activities | -$76.56M |
| Net Cash Flow From Investing Activities, Continuing | -$76.56M |
| Net Cash Flow From Financing Activities | -$19.91M |
| Net Cash Flow From Financing Activities, Continuing | -$19.91M |
| Exchange Gains/Losses | $3.59M |
| Net Cash Flow | -$67.01M |
| Net Cash Flow, Continuing | -$70.60M |
| Comprehensive Income/Loss | $45.79M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $8.56M |
| Comprehensive Income/Loss Attributable To Parent | $37.24M |
| Other Comprehensive Income/Loss | $48.72M |